At Microdose for Peace, we believe that when people feel more balanced, adaptable, and emotionally strong, they are better equipped to navigate life’s challenges and build healthier relationships. Research suggests that emotional regulation, cognitive flexibility, and self-awareness are key factors in building resilience, reducing stress, and enhancing social connections (Carhart-Harris & Goodwin, 2017). While much of this research has focused on the effects of full-dose psychedelic experiences, emerging studies indicate that microdosing may also contribute to these benefits in a more subtle and gradual manner.
For centuries, indigenous cultures have engaged with psychoactive fungi in ritual and healing contexts, emphasizing their role in spiritual and communal well-being (Guzmán, 2008). Contemporary research acknowledges these traditions and explores their potential through a modern scientific lens. Studies on macrodosing suggest that psilocybin can enhance neuroplasticity, disrupt the default mode network, shift entrenched thought patterns, and foster emotional openness, all of which contribute to greater psychological stability and social connectedness (Griffiths et al., 2016). While the effects of microdosing remain an active area of investigation, early reports suggest similar, yet milder effects that may help individuals cultivate emotional adaptability and a greater sense of well-being (Anderson et al., 2021).
Microdosing provides a structured way to explore these potential benefits at sub-perceptual doses. Research indicates that individuals who microdose report improved mood, enhanced creativity, and increased cognitive flexibility (Anderson et al., 2021). Although controlled studies are ongoing to better understand these effects, extensive self-reported findings suggest promising applications, particularly in supporting emotional balance and fostering mindfulness in daily life. Additionally, clinical research on full-dose psilocybin therapy has demonstrated significant benefits in trauma recovery and psychological insight (Reiff et al., 2020), raising important questions about whether lower doses might also play a role in long-term mental health strategies.
While more research is needed to fully understand microdosing’s impact, the growing body of scientific inquiry, combined with centuries of traditional use, suggests that psilocybin may offer meaningful benefits for emotional resilience, self-awareness, and social harmony.
Our Consultants


Client Experiences



I had such a great experience working with Roman! I’m consistently impressed with his depth of knowledge and his ability to clearly articulate the evidence for microdosing. His guidance has helped me achieve my goals of improved focus, enhanced mood, and greater access to creativity. On top of all that, Roman is thoughtful, friendly, and good humored, which put me at ease and made the experience of working with him really enjoyable. I can’t recommend him enough.

free 15 Minute Consultation – Schedule here:
References
- Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L.-A., Hui, K., & Hapke, E. (2021). Psychedelic microdosing benefits and challenges: An empirical codebook. Scientific Reports, 11(1), 2231. https://doi.org/10.1038/s41598-021-01811-4
- Carhart-Harris, R. L., & Goodwin, G. M. (2017). The therapeutic potential of psychedelic drugs: Past, present, and future. Neuropsychopharmacology, 42(11), 2105-2113. https://doi.org/10.1038/npp.2017.84
- Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer. Journal of Psychopharmacology, 30(12), 1181-1197. https://doi.org/10.1177/0269881116675513
- Guzmán, G. (2008). Hallucinogenic mushrooms in Mexico: An overview. Economic Botany, 62(3), 404-412. https://doi.org/10.1007/s12231-008-9033-8
- Reiff, C. M., Richman, E. E., Nemeroff, C. B., Carpenter, L. L., Widge, A. S., Rodriguez, C. I., Kalin, N. H., & McDonald, W. M. (2020). Psychedelics and psychedelic-assisted psychotherapy. American Journal of Psychiatry, 177(5), 391-410. https://doi.org/10.1176/appi.ajp.2019.19010035